Masimo (MASI) Net Margin (2009 - 2026)
Masimo's quarterly Net Margin came in at 0.2% in Q2 2026, up 5877.0% year-on-year from 0.0% in Q2 2025, and down 87.22% quarter-over-quarter from 1.55% in Q1 2026.
Masimo has reported Net Margin for 18 years, with the latest figure at 0.2% in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 5877.0% year-over-year to 0.2%; the trailing twelve-month figure through Apr 2026 stood at 9.02% (up 2782.0% YoY), and the FY2026 full-year result was 23.52%, down 51.0% from the prior year.
- Net Margin for Q2 2026 stood at 0.2%, down from 1.55% in the prior quarter.
- The five-year high for Net Margin was 18.31% in Q1 2022, with the low at 77.25% in Q4 2024.
- Average Net Margin over 5 years is 8.46%, with a median of 1.64% recorded in 2026.
- Year-over-year, Net Margin sank 5469 bps in 2025 and jumped 7880 bps in 2026.
- Tracing MASI's Net Margin over 5 years: stood at 5.89% in 2022, then sank by 556 bps to 26.87% in 2023, then sank by 188 bps to 77.25% in 2024, then soared by 46 bps to 41.48% in 2025, then surged by 100 bps to 0.2% in 2026.
- The last three Net Margin figures came in at 0.2% (Q2 2026), 1.55% (Q1 2026), and 41.48% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | 0.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 0.20% |
| Jan 3, 2026 | 1.55% |
| Sep 27, 2025 | -41.48% |
| Jun 28, 2025 | 1.73% |
| Mar 29, 2025 | -58.58% |
| Dec 28, 2024 | -77.25% |
| Sep 28, 2024 | -4.22% |
| Jun 29, 2024 | -2.56% |
| Mar 30, 2024 | -3.89% |
| Dec 30, 2023 | -26.87% |
| Sep 30, 2023 | 2.21% |
| Jul 1, 2023 | 3.45% |
| Apr 1, 2023 | 3.77% |
| Dec 31, 2022 | 5.89% |
| Oct 1, 2022 | 6.90% |
| Jul 2, 2022 | 3.20% |
| Apr 2, 2022 | 15.32% |
| Jan 1, 2022 | 18.31% |
| Oct 2, 2021 | 18.80% |
| Jul 3, 2021 | 16.45% |
| Apr 3, 2021 | 17.85% |
| Jan 2, 2021 | 22.00% |
| Sep 26, 2020 | 17.76% |
| Jun 27, 2020 | 18.53% |
| Mar 28, 2020 | 23.91% |
| Dec 28, 2019 | 21.38% |
| Sep 28, 2019 | 21.43% |
| Jun 29, 2019 | 19.55% |
| Mar 30, 2019 | 21.29% |
| Dec 29, 2018 | 21.03% |
| Sep 29, 2018 | 27.13% |
| Jun 30, 2018 | 20.72% |
| Mar 31, 2018 | 21.43% |
| Dec 30, 2017 | -3.72% |
| Sep 30, 2017 | 18.54% |
| Jul 1, 2017 | 23.47% |
| Apr 1, 2017 | 26.21% |
| Dec 31, 2016 | 123.21% |
| Oct 1, 2016 | 16.57% |
| Jul 2, 2016 | 17.39% |
| Apr 2, 2016 | 16.11% |
| Jan 2, 2016 | 17.11% |
| Oct 3, 2015 | 12.41% |
| Jul 4, 2015 | 11.75% |
| Apr 4, 2015 | 12.15% |
| Jan 3, 2015 | 19.10% |
| Sep 27, 2014 | 10.38% |
| Jun 28, 2014 | 9.97% |
| Mar 29, 2014 | 16.16% |
| Dec 28, 2013 | 6.50% |
| Sep 28, 2013 | 11.78% |
| Jun 29, 2013 | 10.66% |
| Mar 30, 2013 | 12.07% |
| Dec 29, 2012 | 9.27% |
| Sep 29, 2012 | 11.39% |
| Jun 30, 2012 | 14.47% |
| Mar 31, 2012 | 13.22% |
| Dec 31, 2011 | 12.61% |
| Oct 1, 2011 | 14.25% |
| Jul 2, 2011 | 15.43% |
| Apr 2, 2011 | 16.06% |
| Jan 1, 2011 | 31.80% |
| Oct 2, 2010 | 16.53% |
| Jul 3, 2010 | 13.90% |
| Apr 3, 2010 | 26.49% |
| Oct 3, 2009 | 15.23% |
| Jul 4, 2009 | 15.86% |